Filing Flows › Neuraxis (NRXS) › Q3 2026 › vs Q3 2025
Neuraxis (NRXS) Q3 2026 vs Q3 2025 (year over year)
Neuraxis's revenue rose $1.2M (+150%) from $811K in Q3 2025 to $2.0M in Q3 2026.
Neuraxis, Q3 2026: revenue $2.0M (+150% year over year), operating margin -324.4%, net loss $6.5M, operating cash flow −$2.3M. The chart draws each line against Q3 2025, the increases inside each band.
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $2.0M | $811K | $1.2M | +150% |
| Other income, net | $33K | −$23K | $56K | — |
| Net loss | $6.5M | $2.1M | $4.4M | +208% |
| Costs & expenses | $8.6M | $2.9M | $5.7M | +193% |
| Operating costs | $8.6M | $2.9M | $5.7M | +196% |
| Cost of revenue | $272K | $135K | $136K | +101% |
| Research & development | $289K | $131K | $158K | +121% |
| Sales & marketing | $1.0M | $763K | $239K | +31% |
| General & admin | $7.0M | $1.9M | $5.2M | +274% |
| Operating cash sources | $6.5M | $2.1M | $4.4M | +208% |
| Depreciation & amortization | $17K | $16K | $1K | +4% |
| Share-based compensation | $4.1M | $161K | $3.9M | 25× |
| Working capital & other | $203K | $518K | −$315K | -61% |
| Cash used in operations | $2.3M | $1.4M | $841K | +59% |
| Net loss absorbed | $6.5M | $2.1M | $4.4M | +208% |
Questions
How much did Neuraxis's revenue grow year over year in Q3 2026?
Neuraxis's revenue rose $1.2M (+150%) from $811K in Q3 2025 to $2.0M in Q3 2026.